Research Highlights

 

 
10th Annual LDI Scientific Retreat
Join us at this year’s conference as we celebrate the 10th edition of the LDI Scientific Retreat!
Thursday, May 2 2019, 8:15 am - 5:30 pm
 
Click here to register


  [MORE...]


 
Obesity, but not age at puberty, associated with increased risk of developing multiple sclerosis
An extensive genetic study conducted at the Lady Davis Institute finds that obesity, rather than early puberty, may be influencing increasing rates of multiple sclerosis.

  [MORE...]


 
Scientific journals fail to enforce standards for reporting on clinical trials in non-regulated health care interventions
Surgery, rehabilitation, psychology, nursing, and nutrition journals fail to enforce registration standards for reporting on clinical trials of healthcare interventions: only 4% of primary trial outcomes c...

  [MORE...]


 
Study shows potential misuse of off-label prescription of gabapentinoid drugs
Epidemiologists at the Lady Davis Institute discover that a drug frequently used as an alternative to opioids in treating pain carries some similar potential risks for patients.

  [MORE...]


 
A new “atlas” of genetic influences on osteoporosis will unlock better treatment options
Identifying more than 500 genetic determinants of bone mineral density, researchers expect to provide new opportunities for the development of novel drugs to prevent or treat osteoporosis.

  [MORE...]


 
Common treatment for type 2 diabetes associated with rare, aggressive cance
Incretin-based drugs used to treat type 2 diabetes are associated with bile-duct cancer, a very rare but also extremely aggressive and deadly cancer, finds a study conducted at the Lady Davis Institute.

  [MORE...]


 
NFL gives significant funding to help youth ‘Shred’ the burden of concussion
Epidemiologist from the Lady Davis Institute serves as co-principal investigator of a ground-breaking pan-Canadian research program on injuries to high school athletes.

  [MORE...]


 
Certain blood pressure drugs linked to increased risk of lung cancer
While the risk for individuals is low, it could translate into large numbers of patients, say researchers from the Lady Davis Institute.

  [MORE...]


 
LDI researcher spearheads psychosocial care for cancer patients in low income countries
In many low to middle income parts of the world, resources for cancer treatment are so overburdened that psychosocial care for patients may be neglected. Dr. Melissa Henry is leading an international effor...

  [MORE...]


 
Promising novel treatment against Alzheimer Disease
Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.

  [MORE...]

123456
Support research at the Lady Davis Institute - Jewish General Hospital